Navigation

Investiment.io
Financial analysis platform

Thermo Fisher Scientific Inc.

TMO โ€ข NYSE

$691.33
โ–ผ8.89 (1.27%)โ€ข REGULAR

Thermo Fisher Scientific Inc.

$691.33
โ–ผ1.3%
๐Ÿ“ŠSummary๐Ÿ“‹SEC Filings๐Ÿ‘ฅInsider Trading
โš–๏ธ

Balance SheetTMO

Balance Sheet Summary

Key balance sheet metrics and financial position for TMO

๐Ÿข
Total Assets
$110,343,000
(in thousands USD)
๐Ÿ“‹
Total Liabilities
N/A
(in thousands USD)
๐Ÿ‘ฅ
Shareholders' Equity
$53,407,000
(in thousands USD)
โš–๏ธ
Debt-to-Equity Ratio
0.73
Long-term Debt / Equity

Balance Sheet Analysis

Analyze assets, liabilities, and equity trends over time

Period:annual

Select Metrics to Compare (4 selected)

Total Assets Trend & Growth

Dec 31, 2021Dec 31, 2022Dec 31, 2023Dec 31, 2024Dec 31, 2025$0.00K$30.00B$60.00B$90.00B$120.00B-5%0%+5%+10%+15%
  • Total Assets
  • Total Assets YoY Growth

Total Liabilities Trend & Growth

Dec 31, 2021Dec 31, 2022Dec 31, 2023Dec 31, 2024Dec 31, 2025$0.00K$1.00K$2.00K$3.00K$4.00K
  • Total Liabilities
  • Total Liabilities YoY Growth

Total Shareholders' Equity Trend & Growth

Dec 31, 2021Dec 31, 2022Dec 31, 2023Dec 31, 2024Dec 31, 2025$0.00K$15.00B$30.00B$45.00B$60.00B0%+2%+4%+6%+8%
  • Total Shareholders' Equity
  • Total Shareholders' Equity YoY Growth

Cash and Cash Equivalents Trend & Growth

Dec 31, 2021Dec 31, 2022Dec 31, 2023Dec 31, 2024Dec 31, 20250.002500000000.005000000000.007500000000.0010000000000.00-55%0%+55%+110%+165%
  • Cash and Cash Equivalents
  • Cash and Cash Equivalents YoY Growth